CPD In Practice
Avsnitt

S1 E2: GLP-1s, Weight Bias and the Future of Obesity Care w/Dr. Jordanna Kapeluto

Dela

Endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care.   

Host: Dr. Chris Morrow

Producer:  Craig Ferguson

Music: "Stand With Me" by Adrian Walther licensed via SoundStripe

(C) 2025 UBC Medicine Learning Network

Episode Timestamps

[00:00] - Introduction and episode overview

[01:38] - Medical diagnosis of obesity: Why it is important to diagnose and treat

[02:27] - Evolution of our understanding of obesity and weight dynamics

[04:30] - Stigma surrounding obesity and patient experiences of weight bias affecting access to appropriate care or diagnostics

[06:14] - Defining and diagnosing obesity

[12:40] - Discussion on GLP-1 agonists

[15:45] - GLP-1 agonists and weight loss

[18:14] - GLP-1s in diabetes treatment

[18:42] - Criteria for using GLP-1s as a weight loss agent

[22:05] - GLP-1s: Downsides and barriers

[26:50] - Guidance for primary care providers on prescribing GPL-1s

[30:27] - Closing thoughts from Dr. Jordanna Kapeluto

[31:50] - Closing remarks from Dr. Chris Morrow on GLP-1 agonists

Studies & Research Mentioned

Rubino F, Bartolomucci A, Buse JB, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;S2213-8587(24)00316-4. doi:10.1016/S2213-8587(24)00316-4

Palmer AB, Roshani R, McCormick JB, Fisher-Hoch SP, Below JE, North KE, Gordon-Larsen P. Excess Adiposity Without Obesity in a High-Risk Population. JAMA Netw Open. 2025 Oct 1;8(10):e2535194. doi: 10.1001/jamanetworkopen.2025.35194. PMID: 41042515; PMCID: PMC12495492.Drucker DJ. The GLP-1 journey: from discovery science to therapeutic impact. J Clin Invest. 2024;134(2):e175634. Published 2024 Jan 16. doi:10.1172/JCI175634 

Eng J, Kleinman WA, Singh L, Singh G, Raufman JP. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem. 1992;267(11):7402-7405.

Quetelet A. Sur l'homme et le développement de ses facultés, ou Essai de physique sociale [A Treatise on Man and the Development of His Faculties]. Bachelier; 1835.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Podden och tillhörande omslagsbild på den här sidan tillhör UBC CPD. Innehållet i podden är skapat av UBC CPD och inte av, eller tillsammans med, Poddtoppen.